Avalon Globocare Corp Annual Shareholders Meeting TranscriptOct 12, 2023- Avalon Globocare Corp Annual Shareholders Meeting TranscriptDec 29, 2022
- Avalon Globocare Corp at LD Micro Main Event TranscriptOct 26, 2022
- Avalon Globocare Corp Annual Shareholders Meeting TranscriptDec 31, 2021
- Avalon Globocare Corp at Benzinga Healthcare Small Cap Conference (Virtual) TranscriptSep 30, 2021
Avalon Globocare Corp at Benzinga Healthcare Small Cap Conference (Virtual) Transcript
Excellent teamwork, thank you so much. So good morning, everyone. My name is David Jin, the President and CEO of Avalon Globocare. It's a great pleasure for me and our CFO, Luisa Ingargiola to join the banks and healthcare conference today. Let's try to move it, okay. As a NASDAQ-listed company, we are in full compliance to SEC policies. For details of our form Ks and Qs filings, please refer to the official SEC website.
Avalon Globocare is a clinical-stage vertically integrated biotechnology company. We are dedicated to develop and deliver innovative and transformative cellular technologies and therapeutics in the field of immuno-oncology. In a nutshell, we aim to cure cancer by designing these living drugs, called CAR T cell therapy.
Our company was founded in 2016 as an OTCQB company. In less than two years, Avalon was successfully uplisted to NASDAQ in December 2018. Our headquarters is located in Freehold Township of New Jersey. Currently, we have approximately 120 full-time employees, including those in our subsidiaries.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
